Annual CFI
$4.28 M
+$9.88 M+176.33%
October 1, 2024
Summary
- As of February 8, 2025, ANIX annual cash flow from investing activities is $4.28 million, with the most recent change of +$9.88 million (+176.33%) on October 1, 2024.
- During the last 3 years, ANIX annual CFI has risen by +$8.19 million (+209.17%).
- ANIX annual CFI is now at all-time high.
Performance
ANIX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$867.00 K
-$1.86 M-68.17%
October 1, 2024
Summary
- As of February 8, 2025, ANIX quarterly cash flow from investing activities is $867.00 thousand, with the most recent change of -$1.86 million (-68.17%) on October 1, 2024.
- Over the past year, ANIX quarterly CFI has increased by +$1.46 million (+246.21%).
- ANIX quarterly CFI is now -69.11% below its all-time high of $2.81 million, reached on October 31, 2021.
Performance
ANIX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$4.28 M
+$1.46 M+51.85%
October 1, 2024
Summary
- As of February 8, 2025, ANIX TTM cash flow from investing activities is $4.28 million, with the most recent change of +$1.46 million (+51.85%) on October 1, 2024.
- Over the past year, ANIX TTM CFI has increased by +$9.88 million (+176.33%).
- ANIX TTM CFI is now -27.61% below its all-time high of $5.91 million, reached on April 30, 2022.
Performance
ANIX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ANIX Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +176.3% | +246.2% | +176.3% |
3 y3 years | +209.2% | +188.5% | +128.7% |
5 y5 years | +913.7% | +188.5% | +128.7% |
ANIX Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +139.9% | -68.2% | +108.7% | -27.6% | +125.4% |
5 y | 5-year | at high | +139.9% | -69.1% | +108.7% | -27.6% | +125.4% |
alltime | all time | at high | +123.8% | -69.1% | +105.3% | -27.6% | +123.4% |
Anixa Biosciences Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Oct 2024 | $4.28 M(-176.3%) | $867.00 K(-68.2%) | $4.28 M(+51.8%) |
Jul 2024 | - | $2.72 M(+389.9%) | $2.82 M(-417.1%) |
Apr 2024 | - | $556.00 K(+331.0%) | -$888.00 K(-81.8%) |
Jan 2024 | - | $129.00 K(-121.8%) | -$4.89 M(-12.7%) |
Oct 2023 | -$5.60 M(-47.8%) | -$593.00 K(-39.5%) | -$5.60 M(-62.5%) |
Jul 2023 | - | -$980.00 K(-71.5%) | -$14.93 M(-11.5%) |
Apr 2023 | - | -$3.44 M(+488.7%) | -$16.86 M(+28.1%) |
Jan 2023 | - | -$585.00 K(-94.1%) | -$13.16 M(+22.7%) |
Oct 2022 | -$10.73 M(+173.9%) | -$9.92 M(+240.7%) | -$10.73 M(-637.5%) |
Jul 2022 | - | -$2.91 M(-1264.4%) | $2.00 M(-66.2%) |
Apr 2022 | - | $250.00 K(-86.5%) | $5.91 M(-315.4%) |
Jan 2022 | - | $1.85 M(-34.1%) | -$2.74 M(-30.0%) |
Oct 2021 | -$3.92 M(+1180.9%) | $2.81 M(+180.7%) | -$3.92 M(-37.1%) |
Jul 2021 | - | $1.00 M(-111.9%) | -$6.22 M(-19.6%) |
Apr 2021 | - | -$8.40 M(-1344.3%) | -$7.74 M(-955.7%) |
Jan 2021 | - | $675.00 K(+35.0%) | $905.00 K(-395.9%) |
Oct 2020 | -$305.80 K(-41.8%) | $500.00 K(-196.2%) | -$305.80 K(-71.0%) |
Jul 2020 | - | -$520.00 K(-308.0%) | -$1.06 M(-1024.5%) |
Apr 2020 | - | $250.00 K(-146.7%) | $114.20 K(-108.7%) |
Jan 2020 | - | -$535.80 K(+114.3%) | -$1.31 M(+149.5%) |
Oct 2019 | -$525.50 K(-136.0%) | -$250.00 K(-138.5%) | -$525.50 K(-212.3%) |
Jul 2019 | - | $650.00 K(-155.3%) | $467.90 K(-127.5%) |
Apr 2019 | - | -$1.18 M(-570.2%) | -$1.70 M(-297.0%) |
Jan 2019 | - | $250.00 K(-66.4%) | $864.10 K(-40.9%) |
Oct 2018 | $1.46 M(-153.4%) | $743.40 K(-148.9%) | $1.46 M(-2.6%) |
Jul 2018 | - | -$1.52 M(-209.3%) | $1.50 M(+47.6%) |
Apr 2018 | - | $1.39 M(+64.1%) | $1.02 M(-150.3%) |
Jan 2018 | - | $847.50 K(+8.3%) | -$2.02 M(-26.0%) |
Oct 2017 | -$2.74 M(-281.9%) | $782.70 K(-139.1%) | -$2.74 M(+15.4%) |
Jul 2017 | - | -$2.00 M(+21.4%) | -$2.37 M(+1883.1%) |
Apr 2017 | - | -$1.65 M(-1314.1%) | -$119.50 K(-108.0%) |
Jan 2017 | - | $135.90 K(-88.2%) | $1.50 M(-0.5%) |
Oct 2016 | $1.50 M(+3226.3%) | $1.15 M(+365.8%) | $1.50 M(+323.0%) |
Jul 2016 | - | $246.50 K(-802.3%) | $355.40 K(+226.4%) |
Apr 2016 | - | -$35.10 K(-124.4%) | $108.90 K(-72.4%) |
Jan 2016 | - | $144.00 K(>+9900.0%) | $394.00 K(+771.7%) |
Oct 2015 | $45.20 K(-101.8%) | $0.00(0.0%) | $45.20 K(-51.0%) |
Jul 2015 | - | $0.00(-100.0%) | $92.30 K(-122.5%) |
Apr 2015 | - | $250.00 K(-222.1%) | -$410.20 K(+56.9%) |
Jan 2015 | - | -$204.80 K(-534.8%) | -$261.50 K(-89.6%) |
Oct 2014 | -$2.51 M(-602.0%) | $47.10 K(-109.4%) | -$2.51 M(-1.8%) |
Jul 2014 | - | -$502.50 K(-226.0%) | -$2.55 M(+24.4%) |
Apr 2014 | - | $398.70 K(-116.3%) | -$2.05 M(-16.2%) |
Jan 2014 | - | -$2.45 M(<-9900.0%) | -$2.45 M(-590.4%) |
Oct 2013 | $499.30 K(-71.4%) | $0.00(-100.0%) | $499.40 K(-47.4%) |
Jul 2013 | - | -$1100.00(-161.1%) | $950.00 K(-38.7%) |
Apr 2013 | - | $1800.00(-99.6%) | $1.55 M(-24.3%) |
Jan 2013 | - | $498.70 K(+10.7%) | $2.05 M(+17.1%) |
Oct 2012 | $1.75 M(-181.8%) | $450.60 K(-24.8%) | $1.75 M(-14.6%) |
Jul 2012 | - | $599.20 K(+20.1%) | $2.05 M(-1116.5%) |
Apr 2012 | - | $499.10 K(+150.8%) | -$201.40 K(-89.7%) |
Jan 2012 | - | $199.00 K(-73.5%) | -$1.96 M(-8.5%) |
Oct 2011 | -$2.14 M(-367.4%) | $749.90 K(-145.5%) | -$2.14 M(-25.9%) |
Jul 2011 | - | -$1.65 M(+31.4%) | -$2.89 M(+516.0%) |
Apr 2011 | - | -$1.26 M(-7662.0%) | -$468.40 K(-159.4%) |
Jan 2011 | - | $16.60 K(+492.9%) | $789.00 K(-1.3%) |
Oct 2010 | $799.70 K(-46.8%) | $2800.00(-99.6%) | $799.70 K(-53.7%) |
Jul 2010 | - | $767.50 K(>+9900.0%) | $1.73 M(+2762.2%) |
Apr 2010 | - | $2100.00(-92.3%) | $60.30 K(-0.2%) |
Jan 2010 | - | $27.30 K(-97.1%) | $60.40 K(-96.0%) |
Oct 2009 | $1.50 M(-108.3%) | $929.00 K(-203.4%) | $1.50 M(+82.2%) |
Jul 2009 | - | -$898.10 K(<-9900.0%) | $824.20 K(-396.9%) |
Apr 2009 | - | $2200.00(-99.9%) | -$277.60 K(-2.6%) |
Jan 2009 | - | $1.47 M(+484.8%) | -$284.90 K(-98.4%) |
Oct 2008 | -$18.00 M(+4693.9%) | $251.20 K(-112.6%) | -$18.00 M(-1.4%) |
Jul 2008 | - | -$2.00 M(>+9900.0%) | -$18.26 M(+12.5%) |
Apr 2008 | - | -$5100.00(-100.0%) | -$16.23 M(-0.0%) |
Jan 2008 | - | -$16.25 M(>+9900.0%) | -$16.23 M(+4223.1%) |
Oct 2007 | -$375.50 K | -$4700.00(-119.7%) | -$375.50 K(+3137.1%) |
Jul 2007 | - | $23.90 K(-550.9%) | -$11.60 K(-92.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Apr 2007 | - | -$5300.00(-98.6%) | -$146.80 K(+6.5%) |
Jan 2007 | - | -$389.40 K(-208.4%) | -$137.80 K(-157.0%) |
Oct 2006 | $241.80 K(-159.8%) | $359.20 K(-422.7%) | $241.80 K(-301.0%) |
Jul 2006 | - | -$111.30 K(-3108.1%) | -$120.30 K(+862.4%) |
Apr 2006 | - | $3700.00(-137.8%) | -$12.50 K(-97.0%) |
Jan 2006 | - | -$9800.00(+237.9%) | -$412.20 K(+1.9%) |
Oct 2005 | -$404.50 K(+2492.9%) | -$2900.00(-17.1%) | -$404.70 K(-1.1%) |
Jul 2005 | - | -$3500.00(-99.1%) | -$409.10 K(+0.3%) |
Apr 2005 | - | -$396.00 K(>+9900.0%) | -$407.80 K(+2548.1%) |
Jan 2005 | - | -$2300.00(-68.5%) | -$15.40 K(-1.3%) |
Oct 2004 | -$15.60 K(+1460.0%) | -$7300.00(+231.8%) | -$15.60 K(+88.0%) |
Jul 2004 | - | -$2200.00(-38.9%) | -$8300.00(+16.9%) |
Apr 2004 | - | -$3600.00(+44.0%) | -$7100.00(+102.9%) |
Jan 2004 | - | -$2500.00(<-9900.0%) | -$3500.00(+250.0%) |
Oct 2003 | -$1000.00(-97.4%) | $0.00(-100.0%) | -$1000.00(-75.0%) |
Jul 2003 | - | -$1000.00(<-9900.0%) | -$4000.00(-29.8%) |
Apr 2003 | - | $0.00(0.0%) | -$5700.00(-58.1%) |
Jan 2003 | - | $0.00(-100.0%) | -$13.60 K(-64.8%) |
Oct 2002 | -$38.60 K(-147.7%) | -$3000.00(+11.1%) | -$38.60 K(+8.4%) |
Jul 2002 | - | -$2700.00(-65.8%) | -$35.60 K(-22.3%) |
Apr 2002 | - | -$7900.00(-68.4%) | -$45.80 K(+20.8%) |
Jan 2002 | - | -$25.00 K(<-9900.0%) | -$37.90 K(-146.8%) |
Oct 2001 | $80.90 K(-77.6%) | $0.00(-100.0%) | $80.90 K(+9.3%) |
Jul 2001 | - | -$12.90 K(<-9900.0%) | $74.00 K(+8.0%) |
Apr 2001 | - | $0.00(-100.0%) | $68.50 K(-249.6%) |
Jan 2001 | - | $93.80 K(-1459.4%) | -$45.80 K(-112.7%) |
Oct 2000 | $360.40 K(-172.1%) | -$6900.00(-62.5%) | $360.40 K(-22.9%) |
Jul 2000 | - | -$18.40 K(-83.9%) | $467.30 K(+21.2%) |
Apr 2000 | - | -$114.30 K(-122.9%) | $385.70 K(-22.9%) |
Jan 2000 | - | $500.00 K(+400.0%) | $500.00 K(-200.0%) |
Oct 1999 | -$500.00 K(-162.5%) | $100.00 K(-200.0%) | -$500.00 K(-266.7%) |
Jul 1999 | - | -$100.00 K(<-9900.0%) | $300.00 K(-50.0%) |
Apr 1999 | - | $0.00(-100.0%) | $600.00 K(-250.0%) |
Jan 1999 | - | -$500.00 K(-155.6%) | -$400.00 K(-150.0%) |
Oct 1998 | $800.00 K(-157.1%) | $900.00 K(+350.0%) | $800.00 K(-172.7%) |
Jul 1998 | - | $200.00 K(-120.0%) | -$1.10 M(-15.4%) |
Apr 1998 | - | -$1.00 M(-242.9%) | -$1.30 M(+160.0%) |
Jan 1998 | - | $700.00 K(-170.0%) | -$500.00 K(-64.3%) |
Oct 1997 | -$1.40 M(+7.7%) | -$1.00 M(<-9900.0%) | -$1.40 M(+100.0%) |
Jul 1997 | - | $0.00(-100.0%) | -$700.00 K(-36.4%) |
Apr 1997 | - | -$200.00 K(0.0%) | -$1.10 M(+10.0%) |
Jan 1997 | - | -$200.00 K(-33.3%) | -$1.00 M(-23.1%) |
Oct 1996 | -$1.30 M(+160.0%) | -$300.00 K(-25.0%) | -$1.30 M(+18.2%) |
Jul 1996 | - | -$400.00 K(+300.0%) | -$1.10 M(0.0%) |
Apr 1996 | - | -$100.00 K(-80.0%) | -$1.10 M(+10.0%) |
Jan 1996 | - | -$500.00 K(+400.0%) | -$1.00 M(+100.0%) |
Oct 1995 | -$500.00 K(+400.0%) | -$100.00 K(-75.0%) | -$500.00 K(0.0%) |
Jul 1995 | - | -$400.00 K(<-9900.0%) | -$500.00 K(+400.0%) |
Apr 1995 | - | $0.00(0.0%) | -$100.00 K(0.0%) |
Jan 1995 | - | $0.00(-100.0%) | -$100.00 K(0.0%) |
Oct 1994 | -$100.00 K(0.0%) | -$100.00 K(<-9900.0%) | -$100.00 K(0.0%) |
Jul 1994 | - | $0.00(0.0%) | -$100.00 K(0.0%) |
Apr 1994 | - | $0.00(0.0%) | -$100.00 K(0.0%) |
Jan 1994 | - | $0.00(-100.0%) | -$100.00 K(0.0%) |
Oct 1993 | -$100.00 K(0.0%) | -$100.00 K(<-9900.0%) | -$100.00 K(-50.0%) |
Jul 1993 | - | $0.00(0.0%) | -$200.00 K(+100.0%) |
Apr 1993 | - | $0.00(0.0%) | -$100.00 K(0.0%) |
Jan 1993 | - | $0.00(-100.0%) | -$100.00 K(0.0%) |
Oct 1992 | -$100.00 K(-105.3%) | -$200.00 K(-300.0%) | -$100.00 K(-104.8%) |
Jul 1992 | - | $100.00 K(>+9900.0%) | $2.10 M(+110.0%) |
Apr 1992 | - | $0.00(0.0%) | $1.00 M(-50.0%) |
Jan 1992 | - | $0.00(-100.0%) | $2.00 M(+5.3%) |
Oct 1991 | $1.90 M(-2000.0%) | $2.00 M(-300.0%) | $1.90 M(-1050.0%) |
Jul 1991 | - | -$1.00 M(-200.0%) | -$200.00 K(-114.3%) |
Apr 1991 | - | $1.00 M(-1100.0%) | $1.40 M(-380.0%) |
Jan 1991 | - | -$100.00 K(0.0%) | -$500.00 K(+400.0%) |
Oct 1990 | -$100.00 K(-94.4%) | -$100.00 K(-116.7%) | -$100.00 K(<-9900.0%) |
Jul 1990 | - | $600.00 K(-166.7%) | $0.00(-100.0%) |
Apr 1990 | - | -$900.00 K(-400.0%) | -$600.00 K(-300.0%) |
Jan 1990 | - | $300.00 K | $300.00 K |
Oct 1989 | -$1.80 M | - | - |
FAQ
- What is Anixa Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Anixa Biosciences?
- What is Anixa Biosciences annual CFI year-on-year change?
- What is Anixa Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Anixa Biosciences?
- What is Anixa Biosciences quarterly CFI year-on-year change?
- What is Anixa Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Anixa Biosciences?
- What is Anixa Biosciences TTM CFI year-on-year change?
What is Anixa Biosciences annual cash flow from investing activities?
The current annual CFI of ANIX is $4.28 M
What is the all time high annual CFI for Anixa Biosciences?
Anixa Biosciences all-time high annual cash flow from investing activities is $4.28 M
What is Anixa Biosciences annual CFI year-on-year change?
Over the past year, ANIX annual cash flow from investing activities has changed by +$9.88 M (+176.33%)
What is Anixa Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of ANIX is $867.00 K
What is the all time high quarterly CFI for Anixa Biosciences?
Anixa Biosciences all-time high quarterly cash flow from investing activities is $2.81 M
What is Anixa Biosciences quarterly CFI year-on-year change?
Over the past year, ANIX quarterly cash flow from investing activities has changed by +$1.46 M (+246.21%)
What is Anixa Biosciences TTM cash flow from investing activities?
The current TTM CFI of ANIX is $4.28 M
What is the all time high TTM CFI for Anixa Biosciences?
Anixa Biosciences all-time high TTM cash flow from investing activities is $5.91 M
What is Anixa Biosciences TTM CFI year-on-year change?
Over the past year, ANIX TTM cash flow from investing activities has changed by +$9.88 M (+176.33%)